| Serial Number | 79159531 |
| Word Mark | EXPRES2ION |
| Filing Date | Friday, March 14, 2014 |
| Status | 739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Tuesday, August 30, 2022 |
| Registration Number | 4893901 |
| Registration Date | Tuesday, February 2, 2016 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, November 17, 2015 |
| Description of Mark | The mark consists of the term "EXPRES2ION" where the "2" is displayed in superscript. |
| Goods and Services | [ Chemicals and polymers for medical or veterinary use for use in separation, binding and purification of biological and chemical materials; chemicals, namely, solid phases for medical or veterinary use for use in separation, binding and purification of biological and chemical materials; ] insect cells, insect cell culture media and cell culture reagents all for medical use [ ; pharmaceutical preparations and substances and therapeutic pharmaceuticals for use in the diagnosis, prophylaxis and treatment of cancers, infectious diseases, autoimmune diseases, ophthalmological diseases, metabolic diseases, respiratory diseases, cardiovascular diseases, genetic diseases, and central nervous system conditions; preparations and compositions for therapeutic use, namely, for activating cells of the immune systems; pharmaceutical preparations for use in the treatment of cancer, infectious diseases and immunodeficiencies; antibody-conjugated beads, antibody-conjugated micro-beads and antibody-conjugated microspheres for promoting a therapeutic effect on the body; biological and biochemical preparations for medical purposes for use in the diagnosis, prophylaxis and treatment of cancers, infectious diseases, autoimmune diseases, ophthalmological diseases, metabolic diseases, respiratory diseases, cardiovascular diseases, genetic diseases, and central nervous system conditions; microbiological and tissue culture media, animal blood and serum, and reagents and kits consisting of chemicals, biochemicals, and reagents, all for medical use; chemicals used for medical purposes, namely, reagents, proteins, cells, reagents containing proteins, ligands, effector molecules, and antibodies for medical use ] |
| Pseudo Mark | EXPRESSION; EXPRES TWO ION |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Biological reagents for scientific and research purposes; biological and chemical preparations for use in biotechnology, namely, [ oligonucleotides, DNA primers, synthetic oligonucleotides, assays, and ] reagents for use in genetic and proteomics research; [ chemicals and polymers other than for medical or veterinary use for use in separation, binding and purification of biological and chemical materials; chemicals, namely, solid phases other than for medical or veterinary use for use in separation, binding and purification of biological and chemical materials; ] reagents containing ligands, effector molecules and antibodies for scientific and medical research use; [ antibody-conjugated micro-beads and antibody-conjugated microspheres all for scientific and medical research use and for activation of immune system cells; ] chemicals, biochemicals and reagents for use in industry, science and research; [ chemical compositions for scientific and industrial use in the preparation of culture media; media for cell/tissue cultures, cell/tissue culture growth supplements, reagents and buffers for use in cell/tissue cultures, transfection reagents, cryopreservation reagents other than for medical or veterinary purposes; ] reagents containing proteins, ligands, effector molecules and antibodies for scientific or medical research use; biological and biochemical preparations for scientific or medical research use, namely, [ oligonucleotides, DNA primers, synthetic oligonucleotides, assays, and ] reagents for use in genetic and proteomics research; reagents and kits consisting of chemicals, biochemicals and reagents, all for scientific or research use; kits for scientific and research use consisting primarily of [ one or more of the following: proteins, nucleic acids, hormones, purification supports, resins, cells, gels, buffers, stains and associated ] reagents for the expression, amplification, purification and analysis of biological samples; protein and kits consisting primarily of [ oligonucleotides, peptide substrates, assays and ] reagents for use in genetic and proteomics research and for research purposes in biochemical laboratories; [ cell lines for use in scientific, laboratory, diagnostic and medical research; ] biological and chemical preparations for use in biotechnology, namely, [ oligonucleotides, DNA primers, synthetic oligonucleotides, assays, and ] reagents for use in genetic and proteomics research; chemical and biological products for use in medical science, namely, [ oligonucleotides, DNA primers, synthetic oligonucleotides, assays, and ] reagents for use in genetic and proteomics research; [ microbiological and tissue culture media, animal blood and serum, and reagents and kits consisting of chemicals, biochemicals, and reagents, all for scientific research; chemicals used for medical research purposes, namely, reagents containing proteins, ligands, effector molecules, and antibodies for medical research use; ] insect cells, insect cell culture media, and cell culture reagents all for medical laboratory use [ ; reagents and kits consisting of chemicals, biochemicals, and reagents, all for medical diagnostic laboratory use ] |
| Goods and Services | [ Medical and scientific research; research and consultation services in the fields of pharmaceuticals, vaccines, medicine, biological sciences, immunotherapy, and medical devices; development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; scientific medical laboratory services; research and development for vaccines and new immunotherapy products for others; scientific and technological services, namely, research and design in the fields of medical diagnostics, vaccines, and pharmaceuticals; industrial analysis and research services in the fields of medical diagnostics, vaccines, and pharmaceuticals; research and development services all relating to science; research and development services all relating to industry in the fields of medical diagnostics, vaccines, and pharmaceuticals; research and development services all relating to science; research and development services all relating to biochemistry and biotechnology; research and development services all relating to products and tools to be used in biotechnical research or in biochemical research; ] laboratory research services in the field of gene cloning, gene expression, electrophoresis, protein purification and analysis, and protein interaction detection [ ; providing research data and other molecular biology information for molecular biology reagents and kits in the fields of science and research; scientific research and development; medical and scientific research in the field of molecular biology; biological research; biological cloning services; providing information on the subject of scientific research in the fields of biochemistry and biotechnology; scientific research in the fields of genetics and genetic engineering; biochemical research and development; chemical, biochemical, biological and bacteriological research and analysis; providing reagent sample testing and diagnostic services for others in the field of science and research related thereto; DNA screening for scientific purposes; genetic mapping for scientific purposes; genetic testing for scientific research purposes; providing scientific information via a web site that gives computer users the ability to upload and share video-based scientific protocols and other scientific-based videos; providing information in the field of molecular biology for scientific research purposes, also via on line searchable databases; providing scientific data in protein purification and analysis, and protein interaction detection; medical and scientific research for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers with prophylactic and/or therapeutic purposes; technical research and consultation services in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices; research and development for new immunotherapy products for others; biopharmaceutical research and development; scientific medical laboratory testing and diagnostic services for scientific research purposes; scientific research, namely, developing customized insect culture media, media formulations, and cell culture reagents, and evaluating culture media for others; contract scientific laboratory services and related consulting focused primarily on protein expressions, cell line development, and biotechnology upstream production process development ] |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 6, 2015 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 6, 2015 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 6, 2015 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Expres2ion Biotechnologies ApS |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Hørsholm DK-2970 DK |
| Party Name | Expres2ion Biotechnologies ApS |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Hørsholm DK-2970 DK |
| Party Name | Expres2ion Biotechnologies ApS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Hørsholm DK-2970 DK |
| Event Date | Event Description |
| Friday, March 17, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, March 17, 2023 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Friday, March 17, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Friday, March 17, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, March 17, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, August 30, 2022 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| Tuesday, August 30, 2022 | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. |
| Tuesday, August 16, 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, March 15, 2022 | TEAS SECTION 71 & 15 RECEIVED |
| Tuesday, February 2, 2021 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Thursday, April 16, 2020 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, December 10, 2018 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, December 10, 2018 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, September 15, 2016 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, July 8, 2016 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, May 4, 2016 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, May 4, 2016 | FINAL DISPOSITION PROCESSED |
| Monday, May 2, 2016 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, February 2, 2016 | REGISTERED-PRINCIPAL REGISTER |
| Friday, November 20, 2015 | NOTIFICATION PROCESSED BY IB |
| Tuesday, November 17, 2015 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 17, 2015 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 4, 2015 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, November 4, 2015 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, October 28, 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, October 14, 2015 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, October 8, 2015 | ASSIGNED TO LIE |
| Thursday, September 10, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 8, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 8, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 8, 2015 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, July 7, 2015 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, July 7, 2015 | FINAL REFUSAL E-MAILED |
| Tuesday, July 7, 2015 | FINAL REFUSAL WRITTEN |
| Friday, June 12, 2015 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, June 12, 2015 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, June 12, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 12, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 12, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 13, 2015 | REFUSAL PROCESSED BY IB |
| Tuesday, February 24, 2015 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, February 24, 2015 | REFUSAL PROCESSED BY MPU |
| Tuesday, February 24, 2015 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, February 23, 2015 | NON-FINAL ACTION WRITTEN |
| Monday, February 23, 2015 | NON-FINAL ACTION WRITTEN |
| Tuesday, February 10, 2015 | APPLICATION FILING RECEIPT MAILED |
| Friday, February 6, 2015 | ASSIGNED TO EXAMINER |
| Friday, February 6, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 5, 2015 | SN ASSIGNED FOR SECT 66A APPL FROM IB |